Skip to main content
Top

2014 | OriginalPaper | Hoofdstuk

8. HIPEC, een nieuwe chirurgische techniek

Auteurs : Patrick Hemmer, Barbara van Leeuwen

Gepubliceerd in: Ontwikkelingen in de oncologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Inleiding

Chirurgie is de hoeksteen van de behandeling van kanker; bij veel maligne tumoren is genezing alleen mogelijk als ze volledig chirurgisch verwijderd worden. Met steeds verfijndere chirurgische technieken is het gelukt de overlevingskansen te vergroten en de morbiditeit van de behandeling te verkleinen. Een voorbeeld is de schildwachtklierprocedure, waarmee men lymfekliermetastasen opspoort zodat de verdere behandeling daarop kan worden afgestemd: deze maakt tegenwoordig standaard deel uit van de chirurgie bij mammacarcinoom. Ook als een tumor is uitgezaaid, kan chirurgie de overlevingskansen soms verbeteren.
Literatuur
1.
go back to reference Jayne DG, Fook S, Loi, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer Br J Surg 2002;89:1545–50.PubMedCrossRef Jayne DG, Fook S, Loi, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer Br J Surg 2002;89:1545–50.PubMedCrossRef
2.
go back to reference Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer 1989;63:364–7.PubMedCrossRef Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer 1989;63:364–7.PubMedCrossRef
3.
go back to reference Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358–63.PubMedCrossRef Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358–63.PubMedCrossRef
4.
go back to reference Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol 2009;27:3677–83.PubMedCentralPubMedCrossRef Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol 2009;27:3677–83.PubMedCentralPubMedCrossRef
6.
go back to reference Mukherjee A, Parvaiz A, Cecil TD, Moran BJ. Pseudomyxoma peritonei usually originates from the appendix: A review of the evidence. Eur J GynOncol 2004;25:411–4. Mukherjee A, Parvaiz A, Cecil TD, Moran BJ. Pseudomyxoma peritonei usually originates from the appendix: A review of the evidence. Eur J GynOncol 2004;25:411–4.
7.
go back to reference Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005;241:300–8.PubMedCentralPubMedCrossRef Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005;241:300–8.PubMedCentralPubMedCrossRef
8.
go back to reference Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012;30:2449–56.PubMedCrossRef Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012;30:2449–56.PubMedCrossRef
9.
go back to reference Verwaal VJ, Van Ruth S, De Bree E, Van Sloothen GW, Van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermicintraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2003;21:3737–43.PubMedCrossRef Verwaal VJ, Van Ruth S, De Bree E, Van Sloothen GW, Van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermicintraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2003;21:3737–43.PubMedCrossRef
10.
go back to reference Verwaal VJ, Bruin S, Boot H, Van Slooten G, Van Tinteren H. 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intra-peritoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008;15:2426–32.PubMedCrossRef Verwaal VJ, Bruin S, Boot H, Van Slooten G, Van Tinteren H. 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intra-peritoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008;15:2426–32.PubMedCrossRef
11.
go back to reference Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2009;16:2152–65.PubMedCrossRef Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2009;16:2152–65.PubMedCrossRef
12.
go back to reference Mahteme H, Hansson J, Berglund A, Påhlman L, Glimelius B, Nygren P, et al. Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 2004;90:403–7.PubMedCentralPubMedCrossRef Mahteme H, Hansson J, Berglund A, Påhlman L, Glimelius B, Nygren P, et al. Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 2004;90:403–7.PubMedCentralPubMedCrossRef
13.
go back to reference Elias D. French multi-institutional registry for colorectal peritoneal carcinomatosis [abstract]. 5th peritonectomy workshop, Oct 2008, Lyon, France. Elias D. French multi-institutional registry for colorectal peritoneal carcinomatosis [abstract]. 5th peritonectomy workshop, Oct 2008, Lyon, France.
14.
go back to reference Battifora A, Mc Caughey WTE. Tumours of the serosal membranes. Washington DC: Armed Forces Institute of Pathology, 1994. Battifora A, Mc Caughey WTE. Tumours of the serosal membranes. Washington DC: Armed Forces Institute of Pathology, 1994.
15.
go back to reference Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005;303:1591–603.CrossRef Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005;303:1591–603.CrossRef
16.
go back to reference Deraco M, Nonaka D, Barati D, Casali P, Rosai J, Younan R, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2006;13:229–37.PubMedCrossRef Deraco M, Nonaka D, Barati D, Casali P, Rosai J, Younan R, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2006;13:229–37.PubMedCrossRef
Metagegevens
Titel
HIPEC, een nieuwe chirurgische techniek
Auteurs
Patrick Hemmer
Barbara van Leeuwen
Copyright
2014
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-0436-3_8